| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Laboratory of Persistent Viral Diseases,* Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana; and the Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
Prion protein (PrP) is expressed in many tissues and is required for susceptibility to scrapie and other prion diseases. To investigate the role of PrP expression in different cell types on pathology in retina and brain after scrapie infection, we examined transgenic mice expressing hamster PrP from the PrP promoter (tg7), the neuron-specific enolase promoter (tgNSE), or the astrocyte-specific glial fibrillary acidic protein promoter (tgGFAP). After intraocular inoculation with hamster scrapie, clinical disease developed in tg7 and tgNSE mice by 100 days and in tgGFAP mice by 350 days. Astrogliosis and scrapie-associated protease-resistant PrP (PrP-res) were detected in retina and brain before clinical onset. Retinal PrP-res was present in high amounts in both tg7 and tgNSE mice, however only tg7 mice developed retinal degeneration and extensive apoptosis. In contrast, in all three lines of mice high levels of brain PrP-res accompanied by neurodegeneration were observed. Thus, PrP expression on neurons or astrocytes was sufficient for development of scrapie-induced degeneration in brain but not in retina. The combined effects of PrP-res production in multiple cell types was required to produce retinal degeneration, whereas in brain PrP-res production by neurons or astrocytes alone was sufficient to cause neuronal damage via direct or indirect mechanisms.
This article has been cited by other articles:
 |
|
 |
|
  C. Riemer, J. Schultz, M. Burwinkel, A. Schwarz, S. W. F. Mok, S. Gultner, T. Bamme, S. Norley, F. van Landeghem, B. Lu, et al. Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3-/- Mice J. Virol., December 15, 2008; 82(24): 12464 - 12471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Bai, J. A. Garver, N. A. Hukriede, and E. A. Burton Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene Nucleic Acids Res., October 8, 2007; 35(19): 6501 - 6516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kercher, C. Favara, J. F. Striebel, R. LaCasse, and B. Chesebro Prion Protein Expression Differences in Microglia and Astroglia Influence Scrapie-Induced Neurodegeneration in the Retina and Brain of Transgenic Mice J. Virol., October 1, 2007; 81(19): 10340 - 10351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Meade-White, B. Race, M. Trifilo, A. Bossers, C. Favara, R. Lacasse, M. Miller, E. Williams, M. Oldstone, R. Race, et al. Resistance to Chronic Wasting Disease in Transgenic Mice Expressing a Naturally Occurring Allelic Variant of Deer Prion Protein J. Virol., May 1, 2007; 81(9): 4533 - 4539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Raymond, L. D. Raymond, K. D. Meade-White, A. G. Hughson, C. Favara, D. Gardner, E. S. Williams, M. W. Miller, R. E. Race, and B. Caughey Transmission and Adaptation of Chronic Wasting Disease to Hamsters and Transgenic Mice: Evidence for Strains J. Virol., April 15, 2007; 81(8): 4305 - 4314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gong, A. Jellali, V. Forster, J. Mutterer, E. Dubus, W. D. Altrock, J. A. Sahel, A. Rendon, and S. Picaud The Toxicity of the PrP106-126 Prion Peptide on Cultured Photoreceptors Correlates with the Prion Protein Distribution in the Mammalian and Human Retina Am. J. Pathol., April 1, 2007; 170(4): 1314 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Greenlee, A. N. Hamir, and M. H. West Greenlee Abnormal prion accumulation associated with retinal pathology in experimentally inoculated scrapie-affected sheep. Vet. Pathol., September 1, 2006; 43(5): 733 - 739. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
